The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
Innovation requires the space for failure and continuous improvement.
The two-day event takes place September 22–23, 2020. Submit an abstract, or register to attend.
Although the medtech industry is expected to enjoy steady growth, device companies are still challenged to attract the skilled labor that manufacturing requires.
The agency is allowing the emergency use of a CDC 2019-nCoV real-time PCR panel.
FDA, CDC and other agencies are trying to foster the development of diagnostics, therapeutics and vaccines that help address the outbreak.
The latest regulations for human and veterinary medicinal products, as well as medical devices, include the mandate to set up databases with detailed information about available products. These databases must be realized and implemented in the near future, and require a concerted effort now if tangible real-world benefits are to follow.
The safety communication notes that patients being monitored via GE’s Healthcare Clinical Information Central Stations and Telemetry Services could be at risk.
Special controls are also provided for reasonable assurance of the safety and effectiveness of the devices impacted by the reclassification.
2020 should be a pivotal year in which the microcosm of medical devices moves out of the shadows and joins the mainstream healthcare conversation.